Cargando…
Glycyrrhetinic acid: A potential drug for the treatment of COVID-19 cytokine storm
BACKGROUND: The cytokine storm (CS) triggered by coronavirus disease 2019 (COVID-19) has caused serious harm to health of humanity and huge economic burden to the world, and there is a lack of effective methods to treat this complication. PURPOSE: In this research, we used network pharmacology and m...
Autores principales: | Li, Huawei, You, Jia, Yang, Xi, Wei, Yuanfeng, Zheng, Lingnan, Zhao, Yaqin, Huang, Ying, Jin, Zhao, Yi, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier GmbH.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9098921/ https://www.ncbi.nlm.nih.gov/pubmed/35636166 http://dx.doi.org/10.1016/j.phymed.2022.154153 |
Ejemplares similares
-
Inspiration for COVID-19 Treatment: Network Analysis and Experimental Validation of Baicalin for Cytokine Storm
por: You, Jia, et al.
Publicado: (2022) -
A Review of the Antiviral Activities of Glycyrrhizic Acid, Glycyrrhetinic Acid and Glycyrrhetinic Acid Monoglucuronide
por: Zuo, Jiawei, et al.
Publicado: (2023) -
Novel Pyroptosis-Related Gene Signatures Identified as the Prognostic Biomarkers for Bladder Carcinoma
por: You, Jia, et al.
Publicado: (2022) -
A simple method for evaluation pharmacokinetics of glycyrrhetinic acid and potential drug-drug interaction between herbal ingredients
por: Zhou, Neng, et al.
Publicado: (2019) -
Modifying glycyrrhetinic acid liposomes with liver-targeting ligand of galactosylated derivative: preparation and evaluations
por: Chen, Jing, et al.
Publicado: (2017)